Virological Outcomes of EVG/COBI/FTC/TDF and EVG/COBI/FTC/TAF in Antiretroviral-Naive HIV-1-Infected Participants with Baseline HIV-1 RNA ≥1, 000, 000 Copies/ml: A Post Hoc Analysis of Phase III Clinical Trials. Issue 1 (January 2018) - Sax, Paul; DeJesus, Edwin; Wohl, David; DeMorin, Jennifer; McColl, Damian; Piontkowsky, David; Cohen, Calvin; Wang, Hui; White, Kirsten; Callebaut, Christian; Rhee, Martin; Das, Moupali; et al.